<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="67787">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02223377</url>
  </required_header>
  <id_info>
    <org_study_id>14-482</org_study_id>
    <secondary_id>CAS-2014-038</secondary_id>
    <nct_id>NCT02223377</nct_id>
  </id_info>
  <brief_title>Satisfactory Analgesia Minimal Emesis in Day Surgeries</brief_title>
  <acronym>SAME-Day</acronym>
  <official_title>Most Effective Opioid Analgesia in Ambulatory Surgeries: a Randomized Control, Investigator Blinded, Parallel Group With Superiority Design Study of Morphine Versus Hydromorphone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently nearly 70% or more surgeries are being done as ambulatory (day care) procedures as
      they offer significant benefit to the patients as well as to the hospitals. Inadequate pain
      relief (30%-40%) and nausea-vomiting form the leading factors affecting the quality of care
      and hence its efficiency. Opioids form the primary modality to treat moderate to severe
      pain, but can also cause significant nausea-vomiting and other side effects. Although
      hydromorphone is five times more potent than morphine, in equianalgesic doses they both
      could provide similar pain relief. They both exert no ceiling effect for their analgesia,
      and hence incomplete or inadequate analgesia is related to the appearance of side effects.
      In this study the investigators shall assess the proportion of patients who satisfy the
      outcome of 'satisfactory analgesia with minimal nausea-vomiting' in ambulatory surgeries,
      assessed at 2 hours after surgery. Patients would be randomized to receive either morphine
      or hydromorphone in the surgical recovery area. All personnel involved with the study would
      be blinded. The investigators will also look to assess the time to discharge and other side
      effects. This will help to choose the better drug, thereby improving pain relief and side
      effects, and also the efficiency of health care delivery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Our combined primary outcome will be proportion of patients with Same Analgesia Minimal Emesis, as compared between the 2 groups.</measure>
    <time_frame>At 2hrs or at the time of discharge from PACU</time_frame>
    <description>Our combined primary outcome will be proportion of patients with SAME, as compared between the 2 groups. Analgesia will be based on Numerical Analogue Scale for Pain 0-10 (appendix 3), and Post-operative nausea and vomiting will be based on Verbal Descriptive Scale 0-5 (appendix 3). These observations will be made at the end of 2 hrs or before (corresponding to the time of discharge from PACU), by the PACU nurse.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severe itching</measure>
    <time_frame>At 2hrs or at the time of discharge from PACU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe sedation</measure>
    <time_frame>At 2hrs or at the time of discharge from PACU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe Respiratory Depression</measure>
    <time_frame>At 2hrs or at the time of discharge from PACU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Ketorolac</measure>
    <time_frame>At 2hrs or at the time of discharge from PACU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean dose of analgesic used</measure>
    <time_frame>5 hours post-admit to hospital</time_frame>
    <description>For a day surgery case, from the time of hospital admittance to discharge from hospital is an average 5 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Score</measure>
    <time_frame>At 5 hours post-admit to hospital</time_frame>
    <description>For a day surgery case, from the time of hospital admittance to discharge from hospital is an average 5 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to discharge from PACU</measure>
    <time_frame>At 2hrs or at the time of discharge from PACU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to discharge from hospital</measure>
    <time_frame>At 5 hours post-admit to hospital</time_frame>
    <description>For a day surgery case, from the time of hospital admittance to discharge from hospital is an average 5 hours.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">532</enrollment>
  <condition>Pain</condition>
  <condition>Post Operative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Analgesia with equipotent doses of Morphine and Hydromorphone will be administered in titrated doses. Doses are 1ml=1mg of morphine or 0.2 mg of hydromorphone. Potency ratio of 1:5 (M: HM).
0.05mg/kg morphine units (rounding off to the nearest 1 ml or 0.5 ml)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydromorphone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Analgesia with equipotent doses of Morphine and Hydromorphone will be administered in titrated doses. Doses are 1ml=1mg of morphine or 0.2 mg of hydromorphone. Potency ratio of 1:5 (M: HM).
0.05mg/kg morphine units (rounding off to the nearest 1 ml or 0.5 ml)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Participant to be asked for their pain score, and if it is more than 4 out of 10 (NAS): to receive the 1st dose within 5 minutes after coming to PACU: 0.04mg/kg morphine units (rounding off to the nearest 1 ml or 0.5 ml); with a maximum of 3 mg of morphine equivalents. Repeat doses: 0.02 mg/kg morphine units every 5-10 minutes to titrate for analgesia and side effects (rounding off to the nearest 1 ml or 0.5 ml)</description>
    <arm_group_label>Morphine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydromorphone</intervention_name>
    <description>Participant to be asked for their pain score, and if it is more than 4 out of 10 (NAS): to receive the 1st dose within 5 minutes after coming to PACU: 0.04mg/kg morphine units (rounding off to the nearest 1 ml or 0.5 ml); with a maximum of 3 mg of morphine equivalents. Repeat doses: 0.02 mg/kg morphine units every 5-10 minutes to titrate for analgesia and side effects (rounding off to the nearest 1 ml or 0.5 ml)</description>
    <arm_group_label>Hydromorphone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ambulatory surgeries producing at least moderate pain-such as cholecystectomy,
             appendicectomy, ovarian cystectomy, inguinal hernia repair, abdominal wall hernias

          -  ability to communicate in English.

        Exclusion Criteria:

          -  allergy to M or HM

          -  patient on regular chronic opioid medication

          -  patient uncontrolled systemic disease

          -  severe obesity with a BMI &gt;35

          -  significant psychological impairment

          -  history of drug addiction or dependence

          -  any planned regional or nerve block other than local anesthesia infiltration patients
             with confirmed sleep apnea

          -  emergency surgeries and urological surgeries
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harsha Shanthanna, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Joseph's Healthcare Hamilton/McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Paul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hamilton Health Sciences/McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Toni Tidy, BHSc</last_name>
    <phone>905-525-9140</phone>
    <phone_ext>21737</phone_ext>
    <email>tonitidy@mcmaster.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James Paul, MD</last_name>
      <phone>905-525-9140</phone>
      <phone_ext>21736</phone_ext>
      <email>paulj@mcmaster.ca</email>
    </contact>
    <investigator>
      <last_name>James Paul, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harsha Shanthanna, MD</last_name>
      <phone>905-522-1155</phone>
      <phone_ext>33853</phone_ext>
      <email>shanthh@mcmaster.ca</email>
    </contact>
    <investigator>
      <last_name>Harsha Shanthanna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Sarin P, Philip BK, Mitani A, Eappen S, Urman RD. Specialized ambulatory anesthesia teams contribute to decreased ambulatory surgery recovery room length of stay. Ochsner J. 2012 Summer;12(2):94-100.</citation>
    <PMID>22778673</PMID>
  </reference>
  <reference>
    <citation>Troy AM, Cunningham AJ. Ambulatory surgery: an overview. Curr Opin Anaesthesiol. 2002 Dec;15(6):647-57.</citation>
    <PMID>17019266</PMID>
  </reference>
  <reference>
    <citation>Shnaider I, Chung F. Outcomes in day surgery. Curr Opin Anaesthesiol. 2006 Dec;19(6):622-9. Review.</citation>
    <PMID>17093366</PMID>
  </reference>
  <reference>
    <citation>Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg. 1999 Sep;89(3):652-8.</citation>
    <PMID>10475299</PMID>
  </reference>
  <reference>
    <citation>Chatterjee S, Rudra A, Sengupta S. Current concepts in the management of postoperative nausea and vomiting. Anesthesiol Res Pract. 2011;2011:748031. doi: 10.1155/2011/748031. Epub 2011 Nov 3.</citation>
    <PMID>22110499</PMID>
  </reference>
  <reference>
    <citation>White PF. Pain management after ambulatory surgery - where is the disconnect? Can J Anaesth. 2008 Apr;55(4):201-7. doi: 10.1007/BF03021503. English, French.</citation>
    <PMID>18378964</PMID>
  </reference>
  <reference>
    <citation>Felden L, Walter C, Harder S, Treede RD, Kayser H, Drover D, Geisslinger G, LÃ¶tsch J. Comparative clinical effects of hydromorphone and morphine: a meta-analysis. Br J Anaesth. 2011 Sep;107(3):319-28. doi: 10.1093/bja/aer200. Epub 2011 Aug 5.</citation>
    <PMID>21841049</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 24, 2016</lastchanged_date>
  <firstreceived_date>August 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Hydromorphone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
